Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Insmed Q3 EPS $(1.75) Misses $(1.38) Estimate, Sales $142.342M Beat $115.604M Estimate

Author: Benzinga Newsdesk | October 30, 2025 06:03am
Insmed (NASDAQ:INSM) reported quarterly losses of $(1.75) per share which missed the analyst consensus estimate of $(1.38) by 27.18 percent. This is a 37.8 percent decrease over losses of $(1.27) per share from the same period last year. The company reported quarterly sales of $142.342 million which beat the analyst consensus estimate of $115.604 million by 23.13 percent. This is a 52.36 percent increase over sales of $93.425 million the same period last year.

Posted In: INSM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist